References

References

1. Aldrich MS: Narcolepsy. N Engl J Med 323:389-394, 1990
   
2. Allen RM: Attenuation of drug-induced anxiety dreams and pavor nocturnus by benzodiazepines. J Clin Psychiatry 44:106-108, 1983
   
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revised. Washington, DC, American Psychiatric Association, 1987
   
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC, American Psychiatric Association, 1994
   
5. American Sleep Disorders Association: Practice parameters for the use of stimulants in the treatment of narcolepsy. Standards of Practice Committee of the American Sleep Disorders Association. Sleep 17:348-351, 1994 (Published erratum appears in Sleep 17:748, 1994)
   
6. Ancoli-Israel S, Seifert AR, Lemon M: Thermal biofeedback and periodic movements in sleep: patients' subjective reports and a case study. Biofeedback Self Regulation 11:177-188, 1986
   
7. Arendt J, Deacon S: Treatment of circadian rhythm disorders - melatonin. Chronobiol Int 14(2):185-204, 1997
   
8. Arnulf I, Homeyer P, Garma L, et al: Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration 64:159-161, 1997
   
9. Atwood CW Jr, Sanders MH, Strollo PJJ: Palatal and nonpalatal surgery for sleep apnea hypopnea syndrome. Clinical Pulmonary Medicine 4:205-212, 1997
   
10. Badia P, Harsh J, Culpepper J, et al: Behavioral control of abnormal breathing in sleep. J Behav Med 11:585-592, 1988
    
11. Baillargeon L, Demers M, Ladouceur R: Stimulus control: nonpharmacological treatment for insomnia. Can Fam Physician 44:73-79, 1998
    
12. Balter MB, Uhlenhuth EH: The beneficial and adverse effects of hypnotics. J Clin Psychiatry 52:16-23, 1991
    
13. Balter MB, Uhlenhuth EH: New epidemiological findings about insomnia and its treatment. J Clin Psychiatry 53 (12, suppl):34-39, 1992
    
14. Bassetti C, Aldrich MS: Idiopathic hypersomnia - a series of 42 patients. Brain 120:1423-1435, 1997
    
15. Beasley CM, Sayler ME, Weiss AM, et al: Fluoxetine: activating and sedating effects at multiple fixed doses. J Clin Psychopharmacol 12:328-333, 1992
    
16. Beck JS: Cognitive Therapy: Basics and Beyond. New York, Guilford, 1995
    
17. Becker PM, Ondo W, Sharon D: Encouraging initial response of restless legs syndrome to pramipexole. Neurology 51:1221-1223, 1998
    
18. Berlin RM: Management of insomnia in hospitalized patients. Ann Intern Med 100:398-404, 1984
    
19. Berlin RM, Qayyum U: Sleepwalking: diagnosis and treatment through the life cycle. Psychosomatics 27:755-760, 1986
    
20. Billiard M: Idiopathic hypersomnia. Neurol Clin 14:573-582, 1996
    
21. Billiard M, Dolenc L, Aldaz C, et al: Hypersomnia associated with mood disorders: a new perspective. J Psychosom Res 38:41-47, 1994
    
22. Bliwise DL, Friedman L, Nekich JC, et al: Prediction of outcome in behaviorally based insomnia treatments. J Behav Ther Exp Psychiatry 26:17-23, 1995
    
23. Boivin DB, Duffy JF, Kronauer RE, et al: Dose-response relationships for resetting of human circadian clock by light. Nature 379:540-542, 1996
    
24. Bootzin RR, Epstein D, Wood JM: Stimulus control instructions, in Case Studies in Insomnia. Edited by Hauri PJ. New York, Plenum, 1991, pp 19-28
    
25. Boulos Z, Campbell SS, Lewy AJ, et al: Light treatment for sleep disorders; consensus report, VII: jet lag. J Biol Rhythms 10:167-176, 1995
    
26. Breslau N, Roth T, Rosenthal L, et al: Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39:411-418, 1996
    
27. Brodeur C, Montplaisir J, Godbout R, et al: Treatment of restless legs syndrome and periodic movements during sleep with l-dopa: a double-blind, controlled study. Neurology 38:1845-1848, 1988
    
28. Brooks JO, Friedman L, Bliwise DL, et al: Use of the wrist actigraph to study insomnia in older adults. Sleep 16:151-155, 1993
    
29. Broughton RJ, Fleming JA, George CF, et al: Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49:444-451, 1997
    
30. Brownell LG, West P, Sweatman P, et al: Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med 307:1037-1042, 1982
    
31. Bunnell DE, Treiber SP, Phillips NH, et al: Effects of evening bright light exposure on melatonin, body temperature and sleep. J Sleep Res 1:17-23, 1992
    
32. Burstein A, Burstein A, Freehold NJ: Treatment of night terrors with imipramine (letter). J Clin Psychiatry 44:82, 1983
    
33. Buysse DJ: Drugs affecting sleep, sleepiness and performance, in Sleep, Sleepiness and Performance. Edited by Monk TH. London, Wiley, 1991, pp 249-306
    
34. Buysse DJ, Reynolds CF: Insomnia, in Handbook of Sleep Disorders. Edited by Thorpy MJ. New York, Marcel Dekker, 1990, pp 375-433
    
35. Buysse DJ, Reynolds CF, Hauri PJ, et al: Diagnostic concordance for sleep disorders using proposed DSM-IV categories: a report from the APA/NIMH DSM-IV field trial. Am J Psychiatry 151:1351-1360, 1994
    
36. Buysse DJ, Reynolds CF, Hoch CC, et al: Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients. Neuropsychopharmacology 14:243-252, 1996
    
37. Buysse DJ, Reynolds CF, Houck PR, et al: Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy? J Clin Psychiatry 58(10):426-432, 1997a
    
38. Buysse DJ, Reynolds CF, Kupfer DJ, et al: Effects of diagnosis on treatment recommendations in chronic insomnia - a report from the APA/NIMH DSM-IV field trial. Sleep 20:542-552, 1997b
    
39. Cannici J, Malcom R, Peek L: Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry 14:251-256, 1983
    
40. Cartwright RD, Lloyd S, Lilie J, et al: Sleep position training as treatment for sleep apnea syndrome: a preliminary study. Sleep 8:87-94, 1985
    
41. Chang PP, Ford DE, Mead LA, et al: Insomnia in young men and subsequent depression: the Johns Hopkins Precursors Study. Am J Epidemiol 146:105-114, 1997
    
42. Chemelli RM, Willie JT, Sinton CM, et al: Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation [see comments]. Cell 98(4):437-451, 1999
    
43. Chesson AL, Wise M, Davila D, et al: Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22:961-968, 1999
    
44. Clark GT, Blumenfeld I, Yoffe N, et al: A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 109:1477-1483, 1996
    
45. Coleman RM, Roffwarg HP, Kennedy SJ, et al: Sleep-wake disorders based on a polysomnographic diagnosis; a national cooperative study. JAMA 247:997-1033, 1982
    
46. Collado-Seidel V, Kazenwadel J, Wetter TC, et al: A controlled study of additional sr-l-dopa in l-dopa-responsive restless legs syndrome with late-night symptoms. Neurology 52:285-290, 1999
    
47. Cooper AJ: Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam. J Clin Psychiatry 48:209-210, 1987
    
48. Currie SR, Wilson KG, Pontefract AJ, et al: Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 68:407-416, 2000
    
49. Czeisler CA, Richardson GS, Coleman RM, et al: Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep 4:1-21, 1981
    
50. Czeisler CA, Allan JS, Strogatz SH, et al: Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle. Science 233:667-671, 1986
    
51. Dagan Y, Yovel I, Hallis D, et al: Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS). Chronobiol Int 15(2):181-190, 1998
    
52. Dahlitz M, Alvarez B, Vignau J, et al: Delayed sleep phase syndrome response to melatonin. Lancet 337:1121-1124, 1991
    
53. Dashevsky BA, Kramer M: Behavioral treatment of chronic insomnia in psychiatrically ill patients. J Clin Psychiatry 59:693-699, 1998
    
54. Dawson D, Campbell SS: Timed exposure to bright light improves sleep and alertness during simulated night shifts. Sleep 14:511-516, 1991
    
55. Diagnostic Classification Steering Committee (Thorpy MJ, Chairman): International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, MN, American Sleep Disorders Association, 1990
    
56. Dijk DJ, Cajochen C, Borbely AA: Effect of a single 3-hour exposure to bright light on core body temperature and sleep in humans. Neurosci Lett 121:59-62, 1991
    
57. Earley CJ, Yaffee JB, Allen RP: Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 51:1599-1602, 1998
    
58. Eastman CI, Steward KT, Mahoney MP, et al: Dark goggles and bright light improve circadian rhythm adaptation to shift work. Sleep 17:535-543, 1994
    
59. Eastman CI, Boulos Z, Terman M, et al: Light treatment for sleep disorders: consensus report, VI: shift work. J Biol Rhythms 10:157-164, 1995
    
60. Edelstein B, Keaton-Brasted C, Burg M: Effects of caffeine withdrawal on nocturnal enuresis, insomnia, and behavior restraints. J Consult Clin Psychol 52:857-862, 1984
    
61. Edinger JD, Hoelscher TJ, Webb MD, et al: Polysomnographic assessment of DIMS: empirical evaluation of its diagnostic value. Sleep 12:315-322, 1989a
    
62. Edinger JD, Lipper S, Wheeler B: Hospital ward policy and patients' sleep patterns: a multiple baseline study. Rehabilitation Psychology 34:43-50, 1989b
    
63. Edinger JD, Fins AI, Sullivan RJ, et al: Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep 19:442-444, 1996
    
64. Espie CA: The Psychological Treatment of Insomnia. New York, Wiley, 1991
    
65. Espie CA, Lindsay WR, Brooks DN: Substituting behavioural treatment for drugs in the treatment of insomnia: an exploratory study. J Behav Ther Exp Psychiatry 19:51-56, 1988
    
66. Espie CA, Inglis SJ, Tessier S, et al: The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther 39:45-60, 2001
    
67. Fawcett J, Kravitz HM, Zajecka JM, et al: CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression. J Clin Psychopharmacol 11:127-132, 1991
    
68. Ferguson KA, Ono T, Lowe AA, et al: A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 109:1269-1275, 1996
    
69. Fisher C, Kahn E, Edwards A, et al: A psychophysiological study of nightmares and night terrors: the suppression of stage 4 night terrors with diazepam. Arch Gen Psychiatry 28:252-259, 1973
    
70. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA 262:1479-1484, 1989
    
71. Frank NC, Spirito A, Stark L, et al: The use of scheduled awakenings to eliminate childhood sleepwalking. J Pediatr Psychol 22:345-353, 1997
    
72. Frey J, Darbonne C: Fluoxetine suppresses human cataplexy: a pilot study. Neurology 44:707-709, 1994
    
73. Greenblatt DJ: Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry 53:7-13, 1992
    
74. Greenblatt DJ, Harmatz JS, Zinny MA, et al: Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med 317:722-728, 1987
    
75. Grunstein R, Sullivan C: Continuous positive airway pressure for sleep breathing disorders, in Principles and Practice of Sleep Medicine. Edited by Kryger M, Roth T, Dement WC. Philadelphia, PA, WB Saunders, 2000, pp 894-912
    
76. Guilleminault C: Amphetamines and narcolepsy: use of the Stanford database. Sleep 16:199-201, 1993
    
77. Guilleminault C, Philip P: Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 19 (9 suppl):S117-S122, 1996
    
78. Guilleminault C, Silvestri R, Mondini S, et al: Aging and sleep apnea: action of benzodiazepine, acetazolamide, alcohol and sleep deprivation in a healthy elderly group. J Gerontol 39:655-661, 1984
    
79. Guilleminault C, Clerk A, Black J, et al: Nondrug treatment trials in psychophysiologic insomnia. Arch Intern Med 155:838-844, 1995a
    
80. Guilleminault C, Moscovitch A, Leger D: Forensic sleep medicine: nocturnal wandering and violence. Sleep 18:740-748, 1995b
    
81. Gupta S, Popli A, Bathurst E, et al: Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder. Compr Psychiatry 39:160-164, 1998
    
82. Hajak G, Rodenbeck A, Adler L, et al: Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia. Pharmacopsychiatry 29:187-192, 1996
    
83. Hajak G, Clarenbach P, Fischer W, et al: Rebound insomnia after hypnotic withdrawal in insomniac outpatients. Eur Arch Psychiatry Clin Neurosci 248:148-156, 1998
    
84. Halliday G: Direct psychological therapies for nightmares: a review. Clinical Psychological Review 7:501-523, 1987
    
85. Hanzel DA, Proia NG, Hudgel DW: Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 100:416-421, 1991
    
86. Harman EM, Wynne JW, Block AJ: The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest 82:291-294, 1982
    
87. Hauri PJ: Sleep hygiene, relaxation therapy, and cognitive interventions, in Case Studies in Insomnia. Edited by Hauri PJ. New York, Plenum, 1991, pp 65-84
    
88. Hauri PJ: Insomnia: can we mix behavioral therapy with hypnotics when treating insomniacs? Sleep 20:1111-1118, 1997
    
89. Hauri PJ, Wisbey J: Wrist actigraphy in insomnia. Sleep 15:293-301, 1992
    
90. Henderson S, Jorm AF, Scott LR, et al: Insomnia in the elderly: its prevalence and correlates in the general population. Med J Aust 162:22-24, 1995
    
91. Hening W, Allen R, Earley C, et al: The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22:970-999, 1999
    
92. Herings RM, Stricker BH, de Boer A, et al: Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half- life. Arch Intern Med 155:1801-1807, 1995
    
93. Hinze-Selch D, Mullington J, Orth A, et al: Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry 42:260-266, 1997
    
94. Hohagen F, Montero RF, Weiss E, et al: Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics? Eur Arch Psychiatry Clin Neurosci 244:65-72, 1994
    
95. Holmes PE, Corrigan PW, Knight S, et al: Development of a sleep management program for people with severe mental illness. Psychiatric Rehabilitation Journal 19:9-15, 1995
    
96. Hornyak M, Voderholzer U, Hohagen F, et al: Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 21:501-505, 1998
    
97. Hurwitz TD, Mahowald MW, Schenck CH, et al: A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis 179:228-233, 1991
    
98. Jacobs EA, Reynolds CF III, Kupfer DJ, et al: The role of polysomnography in the differential diagnosis of chronic insomnia. Am J Psychiatry 145:346-349, 1988
    
99. Jacobs GD, Benson H, Friedman S: Perceived benefits in a behavioral-medicine insomnia program: a clinical report. Am J Med 100:213-216, 1996
    
100. Jacobsen FM: Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study. J Clin Psychiatry 51:298-302, 1990
     
101. Jenkinson C, Davies RJO, Mullins R, et al: Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353:2100-2105, 1999
     
102. Jewett ME, Rimmer DW, Duffy JF, et al: Human circadian pacemaker is sensitive to light throughout subjective day without evidence of transients. Am J Physiol 273:R1800-R1809, 1997
     
103. Jones CR, Campbell SS, Zone SE, et al: Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans [see comments]. Nat Med 5:1062-1065, 1999
     
104. Kales A, Kales JD: Evaluation and Treatment of Insomnia. New York, Oxford University Press, 1984
     
105. Kales A, Soldatos CR, Caldwell AB, et al: Somnambulism: clinical characteristics and personality patterns. Arch Gen Psychiatry 37:1406-1410, 1980
     
106. Kales A, Soldatos CR, Bixler EO, et al: Early morning insomnia with rapidly eliminated benzodiazepines. Science 220:95-97, 1983
     
107. Kales JD, Kales A, Soldatos CR, et al: Night terrors: clinical characteristics and personality patterns. Arch Gen Psychiatry 37:1413-1417, 1980
     
108. Kales JD, Cadieux RJ, Soldatos CR, et al: Psychotherapy with night-terror patients. Am J Psychother 36:399-407, 1982
     
109. Kallepalli BR, Bhatara VS, Fogas BS, et al: Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders. J Child Adolesc Psychopharmacol 7:97-107, 1997
     
110. Katz DA, McHorney CA: Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 158:1099-1107, 1998
     
111. Kellner R, Neidhardt J, Krakow B, et al: Changes in chronic nightmares after one session of desensitization or rehearsal instructions. Am J Psychiatry 149:659-663, 1992
     
112. Keshavan MS, Reynolds CF, Miewald JM, et al: A longitudinal study of EEG sleep in schizophrenia. Psychiatry Res 59:203-211, 1996
     
113. Kirmil-Gray K, Eagleston JR, Thoresen CE, et al: Brief consultation and stress management treatments for drug-dependent insomnia: effects on sleep quality, self-efficacy, and daytime stress. J Behav Med 8:79-99, 1985
     
114. Klink ME, Quan SF, Kaltenborn WT, et al: Risk factors associated with complaints of insomnia in a general adult population. Arch Intern Med 152:1634-1637, 1992
     
115. Kopelman PG, Elliott MW, Simonds A, et al: Short-term use of fluoxetine in asymptomatic obese subjects with sleep-related hypoventilation. Int J Obes Relat Metab Disord 16:825-830, 1992
     
116. Koski K, Luukinen H, Laippala P, et al: Risk factors for major injurious falls among the home-dwelling elderly by functional abilities. Gerontology 44:232-238, 1998
     
117. Kosten TR, Frank JB, Dan E, et al: Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179:366-370, 1991
     
118. Krakow B, Kellner R, Pathak D, et al: Imagery rehearsal treatment for chronic nightmares. Behav Res Ther 33:837-843, 1995
     
119. Krakow B, Kellner R, Pathak D, et al: Long term reduction of nightmares with imagery rehearsal treatment. Behavioural and Cognitive Psychotherapy 24:135-148, 1996
     
120. Kripke DF: Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J Affect Disord 49:109-117, 1998
     
121. Lack L, Wright H: The effect of evening bright light in delaying the circadian rhythms and lengthening the sleep of early morning awakening insomniacs. Sleep 16:436-443, 1993
     
122. Lacks P, Morin CM: Recent advances in the assessment and treatment of insomnia. J Consult Clin Psychol 60:586-594, 1992
     
123. Lacks P, Powlishta K: Improvement following behavioral treatment for insomnia: clinical significance, long-term maintenance, and predictors of outcome. Behavior Therapy 20:117-134, 1989
     
124. Lammers GL, Arends J, Declerck AC, et al: Gamma-hydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep 16:216-220, 1993
     
125. Lavie P: Effects of midazolam on sleep disturbances associated with westward and eastward flights: evidence for directional effects. Psychopharmacology (Berl) 101:250-254, 1990
     
126. Lewy AJ, Sack RL: Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J Biol Rhythms 12:588-594, 1997
     
127. Lewy AJ, Sack RL, Miller LS, et al: Antidepressant and circadian phase-shifting effects of light. Science 235:352-354, 1987
     
128. Lichstein KL, Johnson RS: Relaxation for insomnia and hypnotic medication use in older women. Psychol Aging 8:103-111, 1993
     
129. Lichstein KL, Wilson NM, Johnson CT: Psychological treatment of secondary insomnia. Psychol Aging 15:232-240, 2000
     
130. Lin L, Faraco J, Li R, et al: The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene [see comments]. Cell 98:365-376, 1999
     
131. Livingston G, Blizard B, Mann A: Does sleep disturbance predict depression in elderly people? A study in inner London [see comments]. Br J Gen Pract 43(376):445-448, 1993
     
132. Lockley SW, Skene DJ, Arendt J, et al: Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 82:3763-3770, 1997
     
133. Maarek L, Cramer P, Attali P, et al: The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice. J Int Med Res 20:162-170, 1992
     
134. Maixner SM, Tandon RM, Eiser AP, et al: Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension (report). Am J Psychiatry 155:1600-1602, 1997
     
135. Manber R, Bootzin RR, Acebo C, et al: The effects of regularizing sleep-wake schedules on daytime sleepiness. Sleep 19:432-441, 1995
     
136. McClusky HY, Milby JB, Switzer PK, et al: Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry 148:121-126, 1991
     
137. Mellinger GD, Balter MB, Uhlenhuth EH: Insomnia and its treatment. Arch Gen Psychiatry 42:225-232, 1985
     
138. Mellman TA, Uhde TW: Patients with frequent sleep panic: clinical findings and response to medication treatment. J Clin Psychiatry 51:513-516, 1990
     
139. Mendelson WB: Safety of short-acting benzodiazepine hypnotics in patients with impaired respiration (letter). Am J Psychiatry 148:1401, 1991
     
140. Merlotti L, Roehrs T, Zorick F, et al: Rebound insomnia: duration of use and individual differences. J Clin Psychopharmacol 11:368-373, 1991
     
141. Metz A, Shader RI: Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. Int Clin Psychopharmacol 5:191-194, 1990
     
142. Metz A, Shader RI: Combination of fluoxetine with pemoline in the treatment of major depressive disorder. Int Clin Psychopharmacol 6:93-96, 1991
     
143. Mignot E, Hayduk R, Black J, et al: HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20:1012-1020, 1997
     
144. Milby JB, Williams V, Hall JN, et al: Effectiveness of combined triazolam-behavioral therapy for primary insomnia. Am J Psychiatry 150:1259-1260, 1993
     
145. Miller NS, Gold MS: Benzodiazepines: a major problem. J Subst Abuse Treat 8:3-7, 1991
     
146. Miller WR, DiPilato M: Treatment of nightmares via relaxation and desensitization: a controlled evaluation. J Consult Clin Psychol 15:870-877, 1983
     
147. Mimeault V, Morin CM: Self-help treatment for insomnia: bibliotherapy with and without professional guidance. J Consult Clin Psychol 67:511-519, 1999
     
148. Mitler MM, Seidel WF, Van Den Hoed J, et al: Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol 4:2-13, 1984
     
149. Mitler MM, Browman CP, Menn SJ, et al: Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep 9:385-392, 1986
     
150. Mitler MM, Poceta S, Menn SJ, et al: Insomnia in the chronically ill, in Case Studies in Insomnia. Edited by Hauri PJ. New York, Plenum, 1991, pp 223-236
     
151. Mitler MM, Erman M, Hajdukovic R: The treatment of excessive somnolence with stimulant drugs. Sleep 16:203-206, 1993
     
152. Mitler MM, Aldrich MS, Koob GF, et al: Narcolepsy and its treatment with stimulants. ASDA standards of practice. Sleep 17:352-371, 1994
     
153. Moldofsky H, Gilbert R, Lue FA, et al: Sleep-related violence. Sleep 18:731-739, 1995
     
154. Monk TH: Shift work, in Principles and Practice of Sleep Medicine, 2nd Edition. Edited by Kryger MH, Roth T, Dement WC. Philadelphia, PA, WB Saunders, 1994, pp 471-476
     
155. Montgomery I, Oswald I, Morgan K, et al: Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 16:139-144, 1983
     
156. Montplaisir J, Lapierre O, Warnes H, et al: The treatment of the restless leg syndrome with or without periodic leg movements in sleep. Sleep 15:391-395, 1992
     
157. Montplaisir J, Nicolas A, Denesle R, et al: Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 52:938-943, 1999
     
158. Morin CM: Insomnia: Psychological Assessment and Management. New York, Guilford, 1993
     
159. Morin CM, Kowatch RA, Barry T, et al: Cognitive-behavior therapy for late-life insomnia. J Consult Clin Psychol 61:137-146, 1993a
     
160. Morin CM, Stone J, Maghakian C: Cognitive-behavior therapy and pharmacotherapy for late-life insomnia (abstract). Sleep Research 22:240, 1993b
     
161. Morin CM, Culbert JP, Schwartz SM: Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151:1172-1180, 1994a
     
162. Morin CM, Stone J, McDonald K, et al: Psychological management of insomnia: a clinical replication series with 100 patients. Behavior Therapy 25:291-309, 1994b
     
163. Morin CM, Bastien CH, Radouco-Thomas M, et al: Late-life insomnia and chronic use of benzodiazepines: medication tapering with and without behavioral interventions (abstract). Sleep 21 (suppl): 145, 1998
     
164. Morin CM, Colecchi C, Stone J, et al: Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 281:991-999, 1999a
     
165. Morin CM, Hauri PJ, Espie CA, et al: Nonpharmacologic treatment of chronic insomnia. Sleep 22:1134-1156, 1999b
     
166. Murtagh DR, Greenwood KM: Identifying effective psychological treatments for insomnia: a meta analysis. J Consult Clin Psychol 63:79-89, 1995
     
167. Nagtegaal JE, Kerkhof GA, Smits MG, et al: Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res 7(2):135-143, 1998
     
168. National Institute of Mental Health: Consensus Conference report: drugs and insomnia - the use of medication to promote sleep. JAMA 251:2410-2414, 1984
     
169. National Institutes of Health: NIH releases statement on behavioral and relaxation approaches for chronic pain and insomnia. Am Fam Physician 53:1877-1880, 1996
     
170. Neidhardt EJ, Krakow B, Kellner R: The beneficial effects of one treatment session and recording of nightmares on chronic nightmare sufferers. Sleep 15:470-473, 1992
     
171. Nierenberg AA, Adler LA, Peselow E, et al: Trazodone for antidepressant-associated insomnia. Am J Psychiatry 151:1069-1072, 1994
     
172. Nofzinger EA, Thase ME, Reynolds CF, et al: Hypersomnia in bipolar depression: a comparison with narcolepsy using the Multiple Sleep Latency Test. Am J Psychiatry 148:1177-1181, 1991
     
173. Nofzinger EA, Buysse DJ, Reynolds CF, et al: Sleep disorders related to another mental disorder (non-substance/primary): a DSM-IV literature review. J Clin Psychiatry 54:244-255, 1994
     
174. Nofzinger EA, Reynolds CF, Thase ME, et al: REM sleep enhancement by bupropion in depressed men. Am J Psychiatry 152:274-276, 1995
     
175. Nolen WA, Haffmans PMJ, Bouvy PF, et al: Hypnotics as concurrent medication in depression: a placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J Affect Disord 28:179-188, 1993
     
176. Nowell PD, Mazumdar S, Buysse DJ, et al: Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 278:2170-2177, 1997
     
177. Ohayon MM, Caulet M: Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 41:457-464, 1996
     
178. Pallesen S, Nordhus IH, Kvale G: Nonpharmacological interventions for insomnia in older adults: a meta-analysis of treatment efficacy. Psychotherapy 35:472-482, 1998
     
179. Parkes JD, Dahlitz M: Amphetamine prescription. Sleep 16:201-203, 1993
     
180. Petrie K, Dawson AG, Thompson L, et al: A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry 33:526-530, 1993
     
181. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee: Practice parameters for the indications for polysomnography and related procedures. Sleep 20:406-422, 1997
     
182. Post GL, Patrick RO, Crowder JE, et al: Estazolam treatment of insomnia in generalized anxiety disorder: a placebo-controlled study. J Clin Psychopharmacol 11:249-253, 1991
     
183. Raiha I, Seppala M, Impivaara O, et al: Chronic illness and subjective quality of sleep in the elderly. Aging (Milano) 6:91-96, 1994
     
184. Rascati K: Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Ther 17:786-790, 1995
     
185. Reid WH, Ahmed I, Levie CA: Treatment of sleepwalking: a controlled study. Am J Psychother 35:27-37, 1981
     
186. Reit M, Buysse D, Reynolds CF, et al: An American Sleep Disorders Association Review - the use of polysomnography in the evaluation of insomnia. Sleep 18:58-70, 1995
     
187. Reynolds CF, Kupfer DJ, Buysse DJ, et al: Subtyping DSM-III-R primary insomnia: a literature review by the DSM-IV Work Group on Sleep Disorders. Am J Psychiatry 148:432-438, 1991
     
188. Rickels K, Morris RJ, Newman H, et al: Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol 23(5-6):234-242, 1983
     
189. Rickels K, Schweizer E, Case WG, et al: Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability. J Clin Psychopharmacol 18:145-153, 1998
     
190. Riedel B, Lichstein KL, Dwyer WO: Sleep compression and sleep education for older insomniacs: self-help versus therapist guidance. Psychol Aging 10:54-63, 1995
     
191. Riedel B, Lichstein KL, Peterson BA, et al: A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs. Behav Modif 22:3-28, 1998
     
192. Roehrs TA, Zorick FJ, Wittig RM, et al: Alerting effects of naps in patients with narcolepsy. Sleep 9:194-199, 1986a
     
193. Roehrs TA, Zorick FJ, Wittig RM, et al: Dose determinants of rebound insomnia. Br J Clin Pharmacol 22:143-147, 1986b
     
194. Rosenthal NE, Joseph-Vanderpool JR, Levendosky AA, et al: Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep 13:354-361, 1990
     
195. Ross RJ, Ball WA, Sullivan KA, et al: Sleep disturbance as the hallmark of posttraumatic stress disorder. Am J Psychiatry 146:697-706, 1989
     
196. Rush AJ, Armitage R, Gillin JC, et al: Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 44:3-14, 1998
     
197. Sack RL, Lewy AJ: Melatonin as a chronobiotic: treatment of circadian desynchrony in night workers and the blind. J Biol Rhythms 12:595-603, 1997
     
198. Sack RL, Lewy AJ, Blood ML, et al: Melatonin administration to blind people: phase advances and entrainment. J Biol Rhythms 6:249-261, 1991
     
199. Sack RL, Lewy AJ, Blood ML, et al: Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab 75:127-134, 1992
     
200. Sadeh A, Hauri PJ, Kripke DF, et al: The role of actigraphy in the evaluation of sleep disorders. Sleep 18:288-302, 1995
     
201. Saletu B, Oberndorfer S, Anderer P, et al: Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: comparative sleep laboratory studies on objective and subjective sleep and awakening quality. Neuropsychobiology 39:151-159, 1999
     
202. Samel A, Wegmann HM: Bright light: a countermeasure for jet lag? Chronobiol Int 14:173-183, 1997
     
203. Sanders MH: Medical therapy for sleep apnea, in Principles and Practice of Sleep Medicine, 2nd Edition. Edited by Kryger MH, Roth T, Dement WC. Philadelphia, PA, WB Saunders, 1994, pp 678-693
     
204. Schenck CH, Mahowald MW: Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 100:333-337, 1996a
     
205. Schenck CH, Mahowald MW: REM sleep parasomnias. Neurol Clin 14:697-720, 1996b
     
206. Schenck CH, Bundlie SR, Ettinger MG, et al: Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9:293-308, 1986
     
207. Schenck CH, Hurwitz TD, Mahowald MW: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 2:224-231, 1993a
     
208. Schenck CH, Hurwitz TD, O'Connor KA, et al: Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 16:457-466, 1993b
     
209. Schenck CH, Boyd JL, Mahowald MW: A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep 20:972-981, 1997
     
210. Schramm E, Hohagen F, Grasshoff U, et al: Test-retest reliability and validity of a structured interview for sleep disorders according to DSM-III-R (SIS-D). Am J Psychiatry 150:867-872, 1993
     
211. Scrima L, Broudy M, Nay KN, et al: Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: diagnostic potential and proposed mechanism of action. Sleep 5:318-328, 1982
     
212. Seidel WF, Roth T, Roehrs TA, et al: Treatment of a 12-hour shift of sleep schedule with benzodiazepines. Science 224:1262-1264, 1984
     
213. Shader RI, Greenblatt D: Use of benzodiazepines in anxiety disorders. N Engl J Med 328:1398-1405, 1993
     
214. Shestatzky M, Greenberg D, Lerer B: A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 24:149-155, 1988
     
215. Skene DJ, Lockley SW, Arendt J: Melatonin in circadian sleep disorders in the blind. Biol Signals Recept 8:90-95, 1999
     
216. Smith PL, Gold AR, Meyers DA, et al: Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 103:850-855, 1985
     
217. Spielman AJ, Saskin P, Thorpy MJ: Treatment of chronic insomnia by restriction of time in bed. Sleep 10:45-56, 1987
     
218. Spitzer RL, Terman M, Williams JB, et al: Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial. Am J Psychiatry 156:1392-1396, 1999
     
219. Standards of Practice Committee of the American Sleep Disorders Association: Practice parameters for the use of polysomnography in the evaluation of insomnia. Sleep 18:55-57, 1995
     
220. Steens RD, Pouliot Z, Millar TW, et al: Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 16:318-326, 1993
     
221. Strayhorn JM, Nash JL: Frightening dreams and dosage schedule of tricyclic and neuroleptic drugs. J Nerv Ment Dis 166:878-880, 1978
     
222. Strollo PJ, Rogers RM: Obstructive sleep apnea. N Engl J Med 334:99-104, 1996
     
223. Suratt PM, McTier RF, Findley LJ, et al: Effect of very-low calorie diets with weight loss on obstructive sleep apnea. Am J Clin Nutr 56:182S-184S, 1992
     
224. Tan TL, Kales JD, Kales A, et al: Inpatient multidimensional management of treatment-resistant insomnia. Psychosomatics 28:266-272, 1987
     
225. Thompson DF, Pierce DR: Drug-induced nightmares. Ann Pharmacother 33:93-98, 1999
     
226. Thorpy MJ, Snyder M, Aloe FS, et al: Short-term triazolam use improves nocturnal sleep of narcoleptics. Sleep 15:212-216, 1992
     
227. Tobin JD Jr: Treatment of somnambulism with anticipatory awakening. J Pediatr 122:426-427, 1993
     
228. US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 43:88-97, 1998
     
229. van der Kolk BA: The drug treatment of post-traumatic stress disorder. J Affect Disord 13:203-213, 1987
     
230. Vgontzas AN, Kales A, Bixler EO, et al: Usefulness of polysomnographic studies in the differential diagnosis of insomnia. Int J Neurosci 82:47-60, 1995
     
231. Vogel GW, Morris D: The effects of estazolam on sleep, performance, and memory: a long-term sleep laboratory study of elderly insomniacs. J Clin Pharmacol 32:647-651, 1992
     
232. Walsh JK, Muehlbach MJ, Schweitzer PK: Acute administration of triazolam for the daytime sleep of rotating shiftworkers. Sleep 7:223-229, 1984
     
233. Walsh JK, Schweitzer PK: Ten-year trends in the pharmacological treatment of insomnia. Sleep 22:371-375, 1999
     
234. Walsh JK, Sugerman JL, Muehlbach MJ, et al: Physiological sleep tendency on a simulated night shift: adaptation and effects of triazolam. Sleep 11:251-264, 1988
     
235. Ware JC, Brown FW, Moorad PJ: Nocturnal myoclonus and tricyclic antidepressants (abstract). Sleep Research 13:72, 1984
     
236. Ware JC, Rose FV, McBrayer RH: The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep 17:544-550, 1994
     
237. Weissman MM, Greenwald S, Nino-Murcia G, et al: The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19:245-250, 1997
     
238. Wetter TC, Lauer CJ, Gillich G, et al: The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res 30:411-419, 1996
     
239. Wetter TC, Stiasny K, Winkelmann J, et al: A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52:944-950, 1999
     
240. Zorick F, Roehrs T, Koshorek G, et al: Patterns of sleepiness in various disorders of excessive daytime somnolence. Sleep 58:S165-S174, 1982